July 12th 2025
Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Burst CME Plus™ - Unveiling Pharmacological Advances in nAMD & DME: From Durability to Applicability
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Retina Specialists: Join us in Long Beach
July 31, 2025 - August 2, 2025
Register Now!
SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application
View More
Rapid Reviews in Retina™: Emerging Updates from Summer 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
September 6, 2025
Register Now!
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D
View More
EyeCon 2025
September 26-27, 2025
Register Now!
Optometrists: Earn COPE CE Credits in Portland or Virtually
October 16-17, 2025
Register Now!
Join us at The Ophthalmology Meeting in Orlando this October
October 18, 2025
Register Now!
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)
View More
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)
View More
Community Practice Connections™: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
Expert Perspectives on Technological Advances in Cataract Surgery
View More
Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy
View More
Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy
View More
(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention
View More
Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs
View More
(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?
View More
(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?
View More
PresbyLASIK versus multifocal refractive IOLs
January 1st 2008PresbyLASIK treatment uses the principles of LASIK surgery to create a multifocal corneal surface aimed at reducing near vision spectacle dependence in presbyopic patients. This treatment constitutes the next step in the correction of presbyopia after monovision LASIK.1-3 Among the presbyLASIK techniques, central presbyLASIK 4 creates a central area, which is hyperpositive for near vision leaving the midperipheral cornea for far vision. 5 Positive clinical results of this surgical technique have been recently reported 4 and also tested objectively with a light propagation algorithm. 6
Laser thermokeratoplasty the ideal choice for presbyopes?
January 1st 2008The development of the excimer laser has allowed more and more refractive surgical procedures to be developed, treating ever-expanding indications. As such, LASIK remains the most popular procedure for surgeons seeking to correct myopia. But what about hyperopia, which is traditionally thought to be more difficult to treat?
Acri.LISA Toric 466 TD: a multitalented IOL
January 1st 2008Ophthalmic surgeons have been implanting multifocal lenses for several years, not only in cataract surgery, but also to offset the accommodation lost as a consequence of age. With the newest generation of lenses, more than 80% of refractive and cataract patients can now enjoy life without glasses.
The new generation Crystalens better than the rest?
January 1st 2008The first generation Crystalens accommodating intraocular lens (IOL) (eyeonics) was approved by the FDA in November 2003 and has since undergone two revisions. The first involved modification of the lens optic to a "square" rather than smooth edge in order to reduce the incidence of asymmetric capsular fibrosis, which could cause capsular contraction and IOL tilt
Finding it hard to educate patients about presbyopia-correcting IOLs?
January 1st 2008Presbyopia Correcting IOLs (PCIOLs) are perhaps the most significant technological advancement in recent ophthalmic history. These lenses not only provide patients with the option of seeing near, intermediate, and distant objects without dependence on glasses for most of their daily activities - they could also become the single most important cornerstone for building a successful ophthalmic practice, both now and in the foreseeable future.
Routine NSAID use questioned based on multiple factors
November 12th 2007Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are often used off-label for multiple purposes in cataract surgery, but such treatment is often being administered with limited supporting evidence and carries a high cost along with potential risks.
ESCRS postoperative endophthalmitis study results minimally affect US practice patterns so far
November 12th 2007According to the results of an online survey conducted by the ASCRS Cataract Clinical Committee, the results of the ESCRS study of endophthalmitis prophylaxis do not appear to have had a significant impact on the practices of US cataract surgeons.
Accommodating lens model continues trend of improved outcomes throughout implant evolution
November 11th 2007A fourth-generation version of an accommodating IOL (HD-100 crystalens, eyeonics) provides excellent uncorrected visual acuity (UCVA) at all distances without degrading contrast acuity, according to the results of an FDA multicenter clinical trial.
Optic capture technique prevents PCO after pediatric cataract surgery
November 11th 2007Posterior continuous curvilinear capsulorhexis (PCCC) with optic capture of a posterior chamber IOL is a safe and effective technique to afford stable IOL fixation and maintain visual axis clarity after cataract surgery in pediatric eyes.
Preliminary results promising for intraoperative wavefront measurement of LRI effect
November 11th 2007Initial experience with intraoperative use of a wavefront analyzer (WaveTec Visions Systems) suggests that it may be a very useful tool for achieving increased accuracy and efficiency in astigmatism correction.